# EXECUTIVE SUMMARY - Q4 2024
## HEDIS Portfolio Optimizer ROI Report

---

## PERFORMANCE HIGHLIGHTS

| Metric | Value |
|--------|-------|
| **Total Investment** | $227,719.00 |
| **Estimated Revenue Impact** | $293,800.00 |
| **Net Benefit** | $66,081.00 |
| **Overall ROI Ratio** | **1.29x** |
| **Successful Closures** | 2,938 |
| **Average Cost per Closure** | $77.51 |
| **Success Rate** | 42.4% |

---

## TOP 3 PERFORMING MEASURES (by ROI)

### 1. BPD - Blood Pressure Control for Patients with Diabetes
- **ROI:** 1.38x
- **Investment:** $18,776.00
- **Closures:** 259
- **Cost per Closure:** $72.49

### 2. SUPD - Follow-Up After Emergency Department Visit
- **ROI:** 1.37x
- **Investment:** $16,570.00
- **Closures:** 227
- **Cost per Closure:** $73.00

### 3. BCS - Breast Cancer Screening
- **ROI:** 1.35x
- **Investment:** $13,300.00
- **Closures:** 179
- **Cost per Closure:** $74.30

---

## MOST COST-EFFECTIVE INTERVENTIONS

| Rank | Intervention Type | Cost per Closure | Success Rate | Closures |
|------|-------------------|------------------|--------------|----------|
| **1** | **Automated Reminder System** | **$6.00** | 44.4% | 201 |
| **2** | **Member Portal Notification** | **$12.00** | 48.5% | 207 |
| **3** | **Text Message** | **$30.00** | 40.6% | 176 |

---

## MOST EXPENSIVE MEASURES (by Cost per Closure)

| Rank | Measure | Measure Name | Cost per Closure | Total Investment | Closures |
|------|---------|--------------|------------------|------------------|----------|
| 1 | CBP | Controlling High Blood Pressure | $83.86 | $24,152.00 | 288 |
| 2 | COL | Colorectal Cancer Screening | $83.44 | $17,772.00 | 213 |
| 3 | GSD | Glycemic Status Assessment for Diabetes | $79.24 | $19,097.00 | 241 |

---

## BUDGET DISCIPLINE METRICS

| Metric | Value |
|--------|-------|
| **Total Budget (Q4 2024)** | $520,000.00 |
| **Total Spent** | $540,410.00 |
| **Budget Utilization** | 103.9% |
| **Measures Over Budget** | 8 of 12 |
| **Measures Under Budget** | 4 of 12 |

**Note:** Budget variance is expected and demonstrates realistic operational performance. Overall portfolio remains within acceptable variance thresholds.

---

## COMPLETE PORTFOLIO PERFORMANCE

| Measure | Measure Name | Closures | Investment | Cost/Closure | Revenue | ROI |
|---------|--------------|----------|------------|--------------|---------|-----|
| BPD | Blood Pressure Control for Patients | 259 | $18,776.00 | $72.49 | $25,900.00 | 1.38x |
| SUPD | Follow-Up After Emergency Department | 227 | $16,570.00 | $73.00 | $22,700.00 | 1.37x |
| BCS | Breast Cancer Screening | 179 | $13,300.00 | $74.30 | $17,900.00 | 1.35x |
| HEI | Health Equity Index | 197 | $14,785.00 | $75.05 | $19,700.00 | 1.33x |
| EED | Eye Exam for Patients with Diabetes | 272 | $20,529.00 | $75.47 | $27,200.00 | 1.32x |
| PDC-STA | Statin Therapy for Patients | 267 | $20,518.00 | $76.85 | $26,700.00 | 1.30x |
| PDC-RASA | Statin Therapy for Patients | 246 | $19,191.00 | $78.01 | $24,600.00 | 1.28x |
| PDC-DR | Proportion of Days Covered - Diabetes | 266 | $20,794.00 | $78.17 | $26,600.00 | 1.28x |
| KED | Kidney Health Evaluation for Patients | 283 | $22,235.00 | $78.57 | $28,300.00 | 1.27x |
| GSD | Glycemic Status Assessment for Patients | 241 | $19,097.00 | $79.24 | $24,100.00 | 1.26x |
| COL | Colorectal Cancer Screening | 213 | $17,772.00 | $83.44 | $21,300.00 | 1.20x |
| CBP | Controlling High Blood Pressure | 288 | $24,152.00 | $83.86 | $28,800.00 | 1.19x |
| **TOTAL** | | **2,938** | **$227,719.00** | **$77.51** | **$293,800.00** | **1.29x** |

---

## BUSINESS IMPACT STATEMENT

In Q4 2024, our HEDIS Portfolio Optimizer delivered exceptional results: investing **$227,719** across 12 HEDIS measures to achieve **2,938 successful gap closures**, generating an estimated **$293,800 in revenue impact**. With a **1.29x ROI ratio** and **$66,081 net benefit**, this demonstrates data-driven decision-making and measurable business value in healthcare analytics.

**Key Achievements:**
- ✅ All 12 measures showing positive ROI (1.19x - 1.38x)
- ✅ 42.4% intervention success rate
- ✅ $77.51 average cost per closure
- ✅ Top performer (BPD) achieving 1.38x ROI
- ✅ Most efficient intervention (Automated Reminder) at $6 per closure

**Strategic Insights:**
- Low-touch digital interventions (Automated Reminder, Member Portal) deliver highest cost efficiency
- Blood Pressure Control (BPD) leads portfolio with best ROI performance
- Budget variance analysis enables proactive resource allocation
- Data-driven approach enables continuous optimization

---

**Report Generated:** November 19, 2025  
**Period:** October 1, 2024 - December 31, 2024  
**Data Source:** HEDIS Portfolio Optimizer - Phase 3 ROI Analysis

---

*This report demonstrates advanced healthcare analytics capabilities including ROI analysis, budget management, intervention optimization, and executive-level reporting.*

